Long term tenofovir disoproxil fumarate for chronic hepatitis B infection is associated with sustained virological, biochemical and serological responses with no detectable resistance

Chan, AlainMarcellin, PatrickTsai, NaokyFlisiak, RobertPetersen, JorgKotzev, IskrenFlaherty, JohnGaggar, AnujKitrinos, KathrynMchutchison, JohnGeorge, JacobButi, MariaGane, Edward2024-01-302024-01-302014-11Chan, A. vd. (2014). "Long term tenofovir disoproxil fumarate for chronic hepatitis B infection is associated with sustained virological, biochemical and serological responses with no detectable resistance". Journal of Gastroenterology and Hepatology, 37(Supplement 3), Special Issue SI, 185-185.0815-9319https://hdl.handle.net/11452/39386eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyHepatitis B.TenofovirTDFTenofovir disoproxil fumarateLong term tenofovir disoproxil fumarate for chronic hepatitis B infection is associated with sustained virological, biochemical and serological responses with no detectable resistanceMeeting Abstract00034520530044818518529Supplement 3, Special Issue SIGastroenterology & hepatology1440-1746